Interestingly, TCF19‐depleted tumors showed an increased level of αSMA around the vessels, suggestive of increased functional pericyte coverage and a potential reduction in vascular permeability that enables tumor cell intravasation (Fig. 7A) [41]. The gene discussed is TCF19; the disease is neoplasm.